bpc-157 clinical trial human 2025 aka Wolverine. This peptide is not FDA-approved, but it is very popular among the biohacking population. Ashley explains the science behind it, but remember, it doesn’t have data yet, so BPC-157 General Info Sheet
Description
Vagus nerve stimulation study showed 37% success rate in treatment-resistant depression patients
For context on the broader regulatory environment affecting research compounds, the research peptides legal status 2026 guide provides essential background
Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation
And is it possible to get rid of one quickly
